First Time Loading...

ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 0.168 USD 0.18%
Updated: May 13, 2024

ReShape Lifesciences Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ReShape Lifesciences Inc
Gross Profit Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
ReShape Lifesciences Inc
NASDAQ:RSLS
Gross Profit
$5.5m
CAGR 3-Years
112%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Gross Profit
$8.1B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
7%
Boston Scientific Corp
NYSE:BSX
Gross Profit
$10.2B
CAGR 3-Years
16%
CAGR 5-Years
8%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Gross Profit
$13.4B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Gross Profit
$22.3B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$4.9B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
13%

See Also

What is ReShape Lifesciences Inc's Gross Profit?
Gross Profit
5.5m USD

Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Gross Profit amounts to 5.5m USD.

What is ReShape Lifesciences Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
9%

Over the last year, the Gross Profit growth was -18%. The average annual Gross Profit growth rates for ReShape Lifesciences Inc have been 112% over the past three years , 9% over the past five years .